Device manufacturer, as written on reports
Hologic: medical device reports filed with FDA
9,893 reports name it as the manufacturer of the device involved, 2005–2026.
- 9,893
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 1,223
- reports, 12 months to August 2026
- 1,242 in the 12 months before
- 45%
- classified as malfunction
- 62.3% across all reports
- 0.6%
- classified as death, as reported
- 0.9% across all reports
9,893 medical device reports received by FDA give Hologic as the manufacturer of the device involved, 0% of the MAUDE database, from April 2005 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
1,223 reports arrived in the 12 months to August 2026, close to the 1,242 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (51.7%), malfunction (45%) and other (1.7%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Novasure Impedance Controlled Ea System | Device, thermal ablation, endometrial | 1,660 | 0 | 0.4% |
| Novasure | Device, thermal ablation, endometrial | 857 | 140 | 0.4% |
| Aptima Sars-Cov-2 Assay | Reagents, 2019-novel coronavirus nucleic acid | 726 | 0 | 0% |
| Biozorb | Marker, radiographic, implantable | 667 | 151 | 0% |
| Selenia Dimensions Mammography Systems, 3D | Digital breast tomosynthesis | 445 | 114 | 0% |
| Brevera Breast Biopsy System | Instrument, biopsy | 318 | 69 | 0% |
| Selenia Dimensions Mammography System 3d | Digital breast tomosynthesis | 255 | 0 | 0% |
| Fluent Fluid Management System | Insufflator, hysteroscopic | 218 | 3 | 0% |
| 3Dimensions | Digital breast tomosynthesis | 193 | 97 | 0% |
| Novasure Suresound | Device, thermal ablation, endometrial | 188 | 7 | 0% |
| Selenia Mammography System | Full field digital, system, x-ray, mammographic | 175 | 0 | 0% |
| Myosure Hysteroscopic Tissue Removal System | Hysteroscope (and accessories) | 158 | 0 | 1.4% |
| Selenia Dimensions Mammography System | Full field digital, system, x-ray, mammographic | 158 | 21 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| MNB | Device, thermal ablation, endometrial | 3,163 | 32% |
| KNW | Instrument, biopsy | 1,131 | 11.4% |
| HIH | Hysteroscope (and accessories) | 988 | 10% |
| OTE | Digital breast tomosynthesis | 978 | 9.9% |
| QJR | Reagents, 2019-novel coronavirus nucleic acid | 889 | 9% |
| NEU | Marker, radiographic, implantable | 833 | 8.4% |
| MUE | Full field digital, system, x-ray, mammographic | 468 | 4.7% |
| HIG | Insufflator, hysteroscopic | 255 | 2.6% |
| IZH | System, x-ray, mammographic | 137 | 1.4% |
| MKQ | Processor, cervical cytology slide, automated | 100 | 1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Hologic reports
How many FDA device reports name Hologic as manufacturer?
9,893 reports through August 2026, 1,223 of them in the latest 12 months.
Which of its brands appear most often?
Novasure Impedance Controlled Ea System (1,660), Novasure (857), Aptima Sars-Cov-2 Assay (726), Biozorb (667) and Selenia Dimensions Mammography Systems, 3D (445).
Which device types does it report on?
device, thermal ablation, endometrial (32%), instrument, biopsy (11.4%), hysteroscope (and accessories) (10%) and digital breast tomosynthesis (9.9%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.